Asymptomatic parenchymal haemorrhage following endovascular treatment : Impact on functional outcome in patients with acute ischaemic stroke
Toscano-Prat, Clara (Institut de Recerca Sant Pau)
Martínez-González, José Pablo (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya))
Guasch-Jiménez, Marina (Institut de Recerca Sant Pau)
Ramos-Pachón, Anna (Institut de Recerca Sant Pau)
Martí-Fàbregas, Joan (Institut de Recerca Sant Pau)
Blanco-Sanroman, Nerea (Institut de Recerca Sant Pau)
Coronel-Coronel, Melissa Fabiola (Institut de Recerca Sant Pau)
Domine, María Constanza (Institut de Recerca Sant Pau)
Martínez-Domeño, Alejandro (Institut de Recerca Sant Pau)
Prats-Sánchez, Luis Antonio (Institut de Recerca Sant Pau)
Marín-Bueno, Rebeca (Institut de Recerca Sant Pau)
Aguilera-Simón, Ana (Institut de Recerca Sant Pau)
Lambea-Gil, Álvaro (Institut de Recerca Sant Pau)
Ezcurra Diaz, Garbiñe (Institut de Recerca Sant Pau)
Camps-Renom, Pol (Institut de Recerca Sant Pau)
Universitat Autònoma de Barcelona

Fecha:	2024
Resumen:	In patients with acute ischaemic stroke (AIS), haemorrhagic transformation (HT) following endovascular treatment (EVT) is associated with poor functional outcome. However, the impact of asymptomatic HT, not linked to neurological deterioration in the acute phase, is unknown. We aimed to investigate the impact of asymptomatic PH1 (aPH1) and PH2 (aPH2) subtypes of HT on the functional outcome of patients treated with EVT. We conducted a retrospective study of patients with AIS who were consecutively admitted to our comprehensive stroke centre between January 2019 and December 2022, and who underwent EVT. We collected clinical, radiological, and procedural data. HTs were categorized according to the Heidelberg classification. The primary outcome was the shift on the modified Rankin Scale (mRS) at 3 months of follow-up. We performed bivariate and multivariable ordinal regression analyses to test the association between aPH1/aPH2 and the primary outcome. We included 314 patients (mean age = 72. 5 years [SD = 13. 6], 171 [54. 5%] women). We detected 54 (17. 2%) patients with HT; 23 (7. 3%) were classified as PH2 (11 asymptomatic) and 17 (5. 4%) as PH1 (16 asymptomatic). The adjusted common odds ratio for aPH2 of worsening 1 point on the 3-month mRS was 3. 32 (95% confidence interval = 1. 16-9. 57, p = 0. 026). No association was observed for aPH1. aPH2 was also independently associated with lower odds of achieving a favourable outcome (mRS = 0-2). Neither aPH1 nor aPH2 was associated with mortality. In patients with AIS treated with EVT, aPH2 is independently associated with unfavourable functional outcome.
Derechos:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original.
Lengua:	Anglès
Documento:	Article ; recerca ; Versió publicada
Materia:	Endovascular treatment ; Haemorrhagic transformation ; Outcome ; Stroke
Publicado en:	European Journal of Neurology, Vol. 31 Núm. 2 (february 2024) , p. e16112, ISSN 1468-1331

DOI: 10.1111/ene.16112
PMID: 37909802

8 p, 593.6 KB

El registro aparece en las colecciones:
Documentos de investigación > Documentos de los grupos de investigación de la UAB > Centros y grupos de investigación (producción científica) > Ciencias de la salud y biociencias > Institut de Recerca Sant Pau
Artículos > Artículos de investigación
Artículos > Artículos publicados